These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25219468)

  • 1. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
    Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
    Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.
    Feng X; Li R; Huang J; Zhang H; Zhu L; Hua B; Tsao BP; Sun L
    Arthritis Res Ther; 2010; 12(2):R59. PubMed ID: 20359360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
    Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ
    Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
    Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
    J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene expression of OAZ pathway in the patients of systemic lupus erythematosus].
    Li RL; Huang J; Sun LY; Feng XB
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(29):2068-71. PubMed ID: 20017333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.
    Rosado MM; Bernardo ME; Scarsella M; Conforti A; Giorda E; Biagini S; Cascioli S; Rossi F; Guzzo I; Vivarelli M; Dello Strologo L; Emma F; Locatelli F; Carsetti R
    Stem Cells Dev; 2015 Jan; 24(1):93-103. PubMed ID: 25036865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-20a-5p in mesenchymal stem cell derived-exosomes from systemic lupus erythematosus patients restored therapeutic effect and Treg immune regulation.
    Ji J; Liang Q; He Q; Chen T; Feng G; Guo H; Wang Y; Xu Y; Chen P; Dong C; Zhao R; Yang J; Sha X; Cao H; Li J; Xia Y; Yang M; Gu Z
    Eur J Pharmacol; 2024 Sep; 979():176862. PubMed ID: 39068974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells suppress B-cell terminal differentiation.
    Asari S; Itakura S; Ferreri K; Liu CP; Kuroda Y; Kandeel F; Mullen Y
    Exp Hematol; 2009 May; 37(5):604-15. PubMed ID: 19375651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients.
    Jost SA; Tseng LC; Matthews LA; Vasquez R; Zhang S; Yancey KB; Chong BF
    ScientificWorldJournal; 2014; 2014():171028. PubMed ID: 24741342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus.
    Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D
    Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice.
    Zhou Z; Li A; Wang Z; Pei F; Xia Q; Liu G; Ren Y; Hu Z
    Hum Immunol; 2013 Mar; 74(3):297-301. PubMed ID: 23220434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li D; Li X; Duan M; Dou Y; Feng Y; Nan N; Zhang W
    Autoimmunity; 2020 Jun; 53(4):201-209. PubMed ID: 32321315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus.
    Wang J; Cheng Q; Wang X; Zu B; Xu J; Xu Y; Zuo X; Shen Y; Wang J; Shen Y
    Am J Med Sci; 2014 Dec; 348(6):465-73. PubMed ID: 25226532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
    Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE.
    Umiker BR; McDonald G; Larbi A; Medina CO; Hobeika E; Reth M; Imanishi-Kari T
    Eur J Immunol; 2014 Oct; 44(10):3093-108. PubMed ID: 25044405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of an IgG plasma cell checkpoint in patients with lupus.
    Suurmond J; Atisha-Fregoso Y; Marasco E; Barlev AN; Ahmed N; Calderon SA; Wong MY; Mackay MC; Aranow C; Diamond B
    J Allergy Clin Immunol; 2019 Apr; 143(4):1586-1597. PubMed ID: 30439406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
    Lin Z; Dan-Rong Y; Xiao-Qing T; Hao W; Hong-Lian G; Xian-Tao K; Ren-Qian Z; Jiyu L
    J Clin Lab Anal; 2007; 21(3):183-7. PubMed ID: 17506477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.